Works matching IS 11750561 AND DT 2018 AND VI 19 AND IP 3


Results: 15
    1

    Tildrakizumab-asmn: What’s in a Name?

    Published in:
    American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 291, doi. 10.1007/s40257-018-0357-6
    By:
    • Yang, Eric J.;
    • Beck, Kristen M.;
    • Liao, Wilson
    Publication type:
    Article
    2

    Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3).

    Published in:
    American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 457, doi. 10.1007/s40257-018-0353-x
    By:
    • Blauvelt, Andrew;
    • Papp, Kim A.;
    • Griffiths, Christopher E. M.;
    • Puig, Luis;
    • Weisman, Jamie;
    • Dutronc, Yves;
    • Kerr, Lisa Farmer;
    • Ilo, Dapo;
    • Mallbris, Lotus;
    • Augustin, Matthias
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    A Review on Pityriasis Rubra Pilaris.

    Published in:
    American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 377, doi. 10.1007/s40257-017-0338-1
    By:
    • Wang, Dingyuan;
    • Chong, Vanessa Cui-Lian;
    • Chong, Wei-Sheng;
    • Oon, Hazel H.
    Publication type:
    Article
    10
    11
    12

    Management of Itch in Atopic Dermatitis.

    Published in:
    American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 319, doi. 10.1007/s40257-017-0335-4
    By:
    • Pavlis, Janelle;
    • Yosipovitch, Gil
    Publication type:
    Article
    13
    14
    15